Spero Therapeutics Inc. Revenue 2016–2025
Spero Therapeutics Inc. annual/quarterly revenue history and growth rate from 2016 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Spero Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 0, a 100.00% decrease year-over-year.
- Spero Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 12000, a 97.77% decrease year-over-year.
- Spero Therapeutics Inc. annual revenue for 2025 was 12.6 M, a 3292.45% increase from 2024.
- Spero Therapeutics Inc. annual revenue for 2024 was 371000, a 60.24% decrease from 2023.
- Spero Therapeutics Inc. annual revenue for 2023 was 933000, a 62.72% decrease from 2022.
- Spero Therapeutics Inc. annual revenue for 2022 was 2.5 M.
Spero Therapeutics Inc. (SPRO) — Frequently Asked Questions
Spero Therapeutics Inc. (SPRO) is a publicly traded US company. It has a market capitalization of $150M. In fiscal 2025 it reported revenue of $13M and net income of $9M. Explore SPRO's stock price, financial statements, earnings history, margins and key ratios below.
What is Spero Therapeutics Inc.'s market cap?
Spero Therapeutics Inc. (SPRO) has a market capitalization of $150M.
What is the SPRO stock price?
SPRO trades at $2.54 (-1.17% on the day).
How much revenue does Spero Therapeutics Inc. make?
Spero Therapeutics Inc. reported revenue of $13M in fiscal 2025.
Is SPRO profitable?
In fiscal 2025, Spero Therapeutics Inc. reported net income of $9M.